Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

62.6K
Overview
62.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

1.4K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

585
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
585
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

420
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
420
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

460
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PLK1 inhibition dampens NLRP3 inflammasome-elicited response in inflammatory disease models.

The Journal of clinical investigation·2023
Same author

Alpha-synuclein aggresomes inhibit ciliogenesis and multiple functions of the centrosome.

Biology open·2020
Same author

Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4<sup>+</sup> T cells to cytokines.

Nature communications·2020
Same author

Upregulation of Cdh1 signaling in the hippocampus attenuates brain damage after transient global cerebral ischemia in rats.

Neurochemistry international·2017
Same author

Membrane progesterone receptor beta (mPRβ/Paqr8) promotes progesterone-dependent neurite outgrowth in PC12 neuronal cells via non-G protein-coupled receptor (GPCR) signaling.

Scientific reports·2017
Same author

MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism.

Nature communications·2017

Related Experiment Video

Updated: Feb 19, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.3K

NLRP3 inflammasome pathways in atherosclerosis.

Marta Baldrighi1, Ziad Mallat2, Xuan Li1

  • 1Department of Medicine, University of Cambridge, The West Forvie Building, Robinson Way, Cambridge, CB2 0SZ, UK.

Atherosclerosis
|November 11, 2017
PubMed
Summary

The NLR family Pyrin domain containing 3 (NLRP3) inflammasome drives atherosclerosis by promoting chronic inflammation in blood vessels. Targeting NLRP3 activation offers a potential therapeutic strategy for this major cause of death.

Keywords:
ASCAtherosclerosisCaspase-1IL-1βNLRP3 inflammasome

More Related Videos

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K

Related Experiment Videos

Last Updated: Feb 19, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.3K
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Molecular Medicine

Background:

  • Atherosclerosis, a leading cause of mortality, involves chronic sterile inflammation in blood vessels.
  • Lipid and damage-associated molecular patterns initiate immune responses within atherosclerotic plaques.
  • The NLR family Pyrin domain containing 3 (NLRP3) inflammasome has been identified as a key factor in atherogenesis.

Purpose of the Study:

  • To review the fundamental cellular and molecular mechanisms of NLRP3 inflammasome activation.
  • To discuss the role of NLRP3 inflammasome activation in atherosclerosis development and progression.
  • To explore current therapeutic strategies targeting NLRP3 inflammasome activation for atherosclerosis.

Main Methods:

  • Literature review of studies on NLRP3 inflammasome activation and atherosclerosis.
  • Analysis of basic cellular and molecular mechanisms underlying inflammasome activation.
  • Synthesis of current findings on the relevance of NLRP3 to atherogenesis.

Main Results:

  • NLRP3 inflammasome activation is a critical component of the inflammatory process in atherosclerosis.
  • Various molecular patterns contribute to the activation of NLRP3 in the context of atherosclerotic plaques.
  • Research has elucidated key pathways involved in NLRP3 inflammasome signaling relevant to cardiovascular disease.

Conclusions:

  • Understanding NLRP3 inflammasome mechanisms is crucial for addressing atherosclerosis.
  • Targeting NLRP3 inflammasome activation presents a promising therapeutic avenue for preventing and treating atherosclerosis.
  • Further research into NLRP3-targeted therapies could significantly impact cardiovascular disease outcomes.